Earnings Per Share, Basic of HERON THERAPEUTICS, INC. /DE/ from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Earnings Per Share, Basic for the quarter ending 31 Dec 2025 was -0.02, a 200% decline year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ Earnings Per Share, Basic for the twelve months ending 31 Dec 2025 was -0.12, a 33% decline year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ annual Earnings Per Share, Basic for 2025 was -0.12, a 33% decline from 2024.
  • HERON THERAPEUTICS, INC. /DE/ annual Earnings Per Share, Basic for 2024 was -0.09, a 89% increase from 2023.
  • HERON THERAPEUTICS, INC. /DE/ annual Earnings Per Share, Basic for 2023 was -0.8, a 52% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 -0.12 -0.02 -0.04 -200% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 -0.08 -0.1 -0.07 -233% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 -0.01 -0.02 +0.04 +67% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 -0.05 0.02 +0.04 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 -0.09 0.02 +0.03 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 -0.12 -0.03 +0.14 +82% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 -0.26 -0.06 +0.29 +83% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 -0.55 -0.02 +0.25 +93% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 -0.8 -0.01 +0.1 +91% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 -0.9 -0.17 +0.21 +55% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 -1.11 -0.35 +0.2 +36% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 -1.31 -0.27 +0.36 +57% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 -1.67 -0.11 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 -0.38 +0.13 +25% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 -0.55 +0.07 +11% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 -0.63 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 -0.51 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 -0.62 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2

HERON THERAPEUTICS, INC. /DE/ Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -0.12 -0.03 -33% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 -0.09 +0.71 +89% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 -0.8 +0.87 +52% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 -1.67 +0.57 +25% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 -2.24 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.